"My Fulbright research aims to leverage bilateral existing expertise in optical-imaging and MRI to collaboratively develop a cost-effective, readily accessible medical imaging platform to aid in the treatment of Alzheimer’s disease. Such a paradigm shift would improve access to screening for Alzheimer’s disease globally, particularly in low to middle income countries."
Peter is a medical imaging scientist undertaking biomedical research utilising advanced neuroimaging at University of Newcastle. Alzheimer’s disease is a gradually progressive neurodegenerative disorder affecting over 32-million people worldwide. The presence of beta-amyloid deposits is one of the hallmarks of Alzheimer’s disease, and is currently thought to commence 15-20 years before obvious cognitive decline.
As a Fulbright Future Scholar, Peter will collaborate with clinicians and biomedical researchers at University of Illinois at Urbana-Champaign on developing new imaging methods for the detection of beta-amyloid to improve early diagnosis and management of Alzheimer’s disease and improve outcomes for patients and their loved ones.